. (2018). Alzheimer's disease biomarker-guided diagnostic workflow using the added value of six combined cerebrospinal fluid candidates: Aβ1-42, total-tau, phosphorylated-tau, NFL, neurogranin, and YKL-40.. Alzheimer's & Dementia : The Journal Of The Alzheimer's Association. https://doi.org/10.1016/j.jalz.2017.11.015 (Original work published 2018)
K Blennow
First name:
K
Last name:
Blennow
. (2018). Neurofilament light protein in blood predicts regional atrophy in Huntington disease. Neurology. https://doi.org/10.1212/WNL.0000000000005005 (Original work published 2018)
. (2018). A new enzyme-linked immunosorbent assay for neurofilament light in cerebrospinal fluid: analytical validation and clinical evaluation. Alzheimer's Research & Therapy, 10(1), 8. https://doi.org/10.1186/s13195-018-0339-1 (Original work published 2018)
. (2018). Synaptic proteins in CSF as potential novel biomarkers for prognosis in prodromal Alzheimer's disease. Alzheimer's Research & Therapy, 10(1), 5. https://doi.org/10.1186/s13195-017-0335-x (Original work published 2018)
. (2019). Plasma neurofilament light chain concentration is increased in anorexia nervosa. Translational Psychiatry, 9(1), 180. https://doi.org/10.1038/s41398-019-0518-2 (Original work published 2019)
. Comparing Glial Fibrillary Acidic Protein (GFAP) in Serum and Plasma Following Mild Traumatic Brain Injury in Older Adults. Frontiers In Neurology, 11, 1054. https://doi.org/10.3389/fneur.2020.01054 (Original work published 2020)